| http://dbpedia.org/ontology/abstract
|
Neuropathix, Inc. is a biopharmaceutical c … Neuropathix, Inc. is a biopharmaceutical company based in Doylestown, Pennsylvania focused on the research and development of pain management and neuroprotective therapeutics. In 2016, through the company's subsidiary Kannalife, Neuropathix discovered KLS-13019 along with other therapeutic agents that prevent neuropathic pain, mitochondrial dysfunction, reduce oxidative stress, and act as anti-inflammatory neuroprotectants. Both KLS-13019 and cannabidiol, prevented the development of CIPN, while only KLS-13019 uniquely reversed neuropathic pain from chemotherapy. KLS-13019 binds to fewer biological targets than cannabidiol and KLS-13019 may possess the unique ability to reverse addictive behaviour, an effect not observed with cannabidiol. Neuropathix family of monotherapeutic small molecules are focused on treating oxidative stress-related diseases, inflammation, chronic pain management and neurodegenerative disorders. In late 2021, Neuropathix subsidiary Kannalife, was awarded a non-dilutive three-year $2.97 Million grant from the National Institute of Neurological Disorders and Stroke (NINDS) and National Institutes of Health (NIH). The three-year study grant is funded through the NIH HEAL Initiative (Helping End Addiction Long-term) for enhanced pain management and provides funding specifically in the Development of KLS-13019 for Neuropathic Pain. Neuropathix is currently conducting research and development at the Pennsylvania Biotechnology Center of Bucks County to treat Chemotherapy-induced peripheral neuropathy, Hepatic encephalopathy, Mild Traumatic Brain Injury and CTE.athy, Mild Traumatic Brain Injury and CTE.
|
| http://dbpedia.org/ontology/foundedBy
|
http://dbpedia.org/resource/Thoma_Kikis +
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Pharmaceutical_industry +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Doylestown%2C_Pennsylvania +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Neuropathix-logo.png?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://neuropathix.com/ +
, http://www.neuropathix.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
67135363
|
| http://dbpedia.org/ontology/wikiPageLength
|
5693
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1067322970
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Oxidative_stress +
, http://dbpedia.org/resource/CIPN +
, http://dbpedia.org/resource/Category:Social_responsibility_organizations +
, http://dbpedia.org/resource/Kannalife +
, http://dbpedia.org/resource/Concussion +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Chronic_traumatic_encephalopathy +
, http://dbpedia.org/resource/KLS-13019 +
, http://dbpedia.org/resource/Biopharmaceutical +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Hepatic_encephalopathy +
, http://dbpedia.org/resource/Neuropathic_pain +
, http://dbpedia.org/resource/Mitochondrial_disease +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Thoma_Kikis +
, http://dbpedia.org/resource/National_Institutes_of_Health +
, http://dbpedia.org/resource/Doylestown%2C_Pennsylvania +
, http://dbpedia.org/resource/Anti-inflammatory +
, http://dbpedia.org/resource/File:Neuropathix-logo.png +
, http://dbpedia.org/resource/Small_molecule +
, http://dbpedia.org/resource/Category:Corporate_social_responsibility +
, http://dbpedia.org/resource/Neuroprotection +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_Pennsylvania +
, http://dbpedia.org/resource/Neurodegeneration +
, http://dbpedia.org/resource/National_Institute_of_Neurological_Disorders_and_Stroke +
, http://dbpedia.org/resource/Chronic_pain +
, http://dbpedia.org/resource/Category:Social_responsibility +
, http://dbpedia.org/resource/Chemotherapy-induced_peripheral_neuropathy +
, http://dbpedia.org/resource/Pharmaceutical_industry +
, http://dbpedia.org/resource/Pain_management +
, http://dbpedia.org/resource/Inflammation +
, http://dbpedia.org/resource/Cannabidiol +
, http://dbpedia.org/resource/Category:Cannabis_research +
, http://dbpedia.org/resource/Category:Companies_based_in_Bucks_County%2C_Pennsylvania +
|
| http://dbpedia.org/property/assets
|
Patents ,
|
| http://dbpedia.org/property/founders
|
Dean Petkanas, Thoma Kikis
|
| http://dbpedia.org/property/homepage
|
http://neuropathix.com/ +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Pharmaceutical_industry +
, http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Doylestown%2C_Pennsylvania +
|
| http://dbpedia.org/property/logo
|
260
|
| http://dbpedia.org/property/name
|
Neuropathix Inc.
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:OTCQB +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Patent +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Infobox_company +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Social_responsibility +
, http://dbpedia.org/resource/Category:Companies_based_in_Bucks_County%2C_Pennsylvania +
, http://dbpedia.org/resource/Category:Corporate_social_responsibility +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Social_responsibility_organizations +
, http://dbpedia.org/resource/Category:Cannabis_research +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_Pennsylvania +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Neuropathix?oldid=1067322970&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Neuropathix-logo.png +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://neuropathix.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Neuropathix +
|
| http://xmlns.com/foaf/0.1/name
|
Neuropathix Inc.
|
| owl:sameAs |
http://www.wikidata.org/entity/Q106311066 +
, https://global.dbpedia.org/id/Fqiqm +
, http://dbpedia.org/resource/Neuropathix +
|
| rdf:type |
http://dbpedia.org/ontology/Agent +
, http://schema.org/Organization +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Company +
|
| rdfs:comment |
Neuropathix, Inc. is a biopharmaceutical c … Neuropathix, Inc. is a biopharmaceutical company based in Doylestown, Pennsylvania focused on the research and development of pain management and neuroprotective therapeutics. In 2016, through the company's subsidiary Kannalife, Neuropathix discovered KLS-13019 along with other therapeutic agents that prevent neuropathic pain, mitochondrial dysfunction, reduce oxidative stress, and act as anti-inflammatory neuroprotectants. Both KLS-13019 and cannabidiol, prevented the development of CIPN, while only KLS-13019 uniquely reversed neuropathic pain from chemotherapy. KLS-13019 binds to fewer biological targets than cannabidiol and KLS-13019 may possess the unique ability to reverse addictive behaviour, an effect not observed with cannabidiol. Neuropathix family of monotherapeutic small moleculix family of monotherapeutic small molecul
|
| rdfs:label |
Neuropathix
|
